Reactivation Versus Clearance of Mycobacterium tuberculosis Using Mammalian Target of Rapamycin Inhibitors in Patients With Cancer Can Be Context Dependent
Author(s) -
Salvador Vale
Publication year - 2013
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2013.49.1225
Subject(s) - temsirolimus , pi3k/akt/mtor pathway , sirolimus , latent tuberculosis , medicine , context (archaeology) , mycobacterium tuberculosis , cancer research , immunology , lung cancer , cancer , immunity , immune system , tuberculosis , biology , oncology , discovery and development of mtor inhibitors , pathology , apoptosis , paleontology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom